Major Thrombotic Event Despite Anticoagulation in a Patient With COVID-19.
| Autor: | Ataallah B; Internal Medicine, Zucker School of Medicine at Mather, Port Jefferson, USA.; Internal Medicine, Northwell Health Mather Hospital, Port Jefferson, USA., Sharma A; Internal Medicine, Zucker School of Medicine at Mather, Port Jefferson, USA., Tamanna S; Internal Medicine, Northwell Health Mather Hospital, Port Jefferson, USA., Ng J; Pulmonary and Critical Care Medicine, Northwell Health Mather Hospital, Port Jefferson, USA., Haggerty G; Graduate Medical Education, Northwell Health Mather Hospital, Port Jefferson, USA.; Internal Medicine, Zucker School of Medicine at Mather, Port Jefferson, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2020 Jun 29; Vol. 12 (6), pp. e8896. Date of Electronic Publication: 2020 Jun 29. |
| DOI: | 10.7759/cureus.8896 |
| Abstrakt: | The outbreak of coronavirus disease 2019 (known as COVID-19), which started in Wuhan, China in December 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been associated with both venous and arterial thromboembolism likely secondary to significant cytokine activation and inflammation. Reports on the incidence of thrombotic complications, however, are not well documented. Our case will examine a young man diagnosed with COVID-19 who developed an acute, severe bilateral saddle pulmonary embolism while on prophylactic dose anticoagulation after being admitted to the hospital and treated for two weeks with significant improvement. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2020, Ataallah et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|